Matches in SemOpenAlex for { <https://semopenalex.org/work/W2918074620> ?p ?o ?g. }
- W2918074620 abstract "Antiretroviral therapy (ART) has transformed HIV from a fatal disease to a chronic condition. In recent years there has been considerable interest in strategies to enable HIV-infected individuals to cease ART without viral rebound, either by purging all cells infected harboring replication-competent virus (HIV eradication), or by boosting immune responses to allow durable suppression of virus without rebound (HIV remission). Both of these approaches may need to harness HIV-specific CD8+ T cells to eliminate infected cells and/or prevent viral spread. In untreated infection, both HIV-specific and total CD8+ T cells are dysfunctional. Here, we review our current understanding of both global and HIV-specific CD8+ T cell immunity in HIV-infected individuals with durably suppressed viral load under ART, and its implications for HIV cure, eradication or remission. Overall, the literature indicates significant normalization of global T cell parameters, including CD4/8 ratio, activation status, and telomere length. Global characteristics of CD8+ T cells from HIV+ART+ individuals align more closely with those of HIV-seronegative individuals than of viremic HIV-infected individuals. However, markers of senescence remain elevated, leading to the hypothesis that immune aging is accelerated in HIV-infected individuals on ART. This phenomenon could have implications for attempts to prime de novo, or boost existing HIV-specific CD8+ T cell responses. A major challenge for both HIV cure and remission strategies is to elicit HIV-specific CD8+ T cell responses superior to that elicited by natural infection in terms of response kinetics, magnitude, breadth, viral suppressive capacity, and tissue localization. Addressing these issues will be critical to the success of HIV cure and remission attempts." @default.
- W2918074620 created "2019-03-02" @default.
- W2918074620 creator A5007488660 @default.
- W2918074620 creator A5018705390 @default.
- W2918074620 creator A5057326864 @default.
- W2918074620 date "2019-02-26" @default.
- W2918074620 modified "2023-10-15" @default.
- W2918074620 title "Harnessing CD8+ T Cells Under HIV Antiretroviral Therapy" @default.
- W2918074620 cites W1515986708 @default.
- W2918074620 cites W1538764015 @default.
- W2918074620 cites W1544333260 @default.
- W2918074620 cites W1573558157 @default.
- W2918074620 cites W1592500890 @default.
- W2918074620 cites W1655510925 @default.
- W2918074620 cites W1674676016 @default.
- W2918074620 cites W1721778868 @default.
- W2918074620 cites W1867898882 @default.
- W2918074620 cites W1894284833 @default.
- W2918074620 cites W1932046647 @default.
- W2918074620 cites W1940065004 @default.
- W2918074620 cites W1950892723 @default.
- W2918074620 cites W1965538807 @default.
- W2918074620 cites W1967684158 @default.
- W2918074620 cites W1967794036 @default.
- W2918074620 cites W1968708587 @default.
- W2918074620 cites W1969004932 @default.
- W2918074620 cites W1969260248 @default.
- W2918074620 cites W1969899610 @default.
- W2918074620 cites W1970924670 @default.
- W2918074620 cites W1971112771 @default.
- W2918074620 cites W1974248438 @default.
- W2918074620 cites W1974393084 @default.
- W2918074620 cites W1974488636 @default.
- W2918074620 cites W1978436252 @default.
- W2918074620 cites W1983790016 @default.
- W2918074620 cites W1983818591 @default.
- W2918074620 cites W1986151024 @default.
- W2918074620 cites W1988354925 @default.
- W2918074620 cites W1991070340 @default.
- W2918074620 cites W1991737813 @default.
- W2918074620 cites W1993891836 @default.
- W2918074620 cites W1994078672 @default.
- W2918074620 cites W1995875735 @default.
- W2918074620 cites W1996464851 @default.
- W2918074620 cites W1998353416 @default.
- W2918074620 cites W2001342405 @default.
- W2918074620 cites W2001815433 @default.
- W2918074620 cites W2002438821 @default.
- W2918074620 cites W2004010450 @default.
- W2918074620 cites W2005281007 @default.
- W2918074620 cites W2006147574 @default.
- W2918074620 cites W2006912293 @default.
- W2918074620 cites W2007607803 @default.
- W2918074620 cites W2008852275 @default.
- W2918074620 cites W2010605331 @default.
- W2918074620 cites W2010686257 @default.
- W2918074620 cites W2017238645 @default.
- W2918074620 cites W2017843172 @default.
- W2918074620 cites W2019405644 @default.
- W2918074620 cites W2020635157 @default.
- W2918074620 cites W2021701724 @default.
- W2918074620 cites W2022385598 @default.
- W2918074620 cites W2026547100 @default.
- W2918074620 cites W2028840312 @default.
- W2918074620 cites W2035121127 @default.
- W2918074620 cites W2035852466 @default.
- W2918074620 cites W2038023416 @default.
- W2918074620 cites W2039473791 @default.
- W2918074620 cites W2039751597 @default.
- W2918074620 cites W2040793589 @default.
- W2918074620 cites W2043402731 @default.
- W2918074620 cites W2043651979 @default.
- W2918074620 cites W2044377869 @default.
- W2918074620 cites W2048088501 @default.
- W2918074620 cites W2049539466 @default.
- W2918074620 cites W2049947898 @default.
- W2918074620 cites W2052629634 @default.
- W2918074620 cites W2053898412 @default.
- W2918074620 cites W2055796578 @default.
- W2918074620 cites W2056833651 @default.
- W2918074620 cites W2057392346 @default.
- W2918074620 cites W2059473808 @default.
- W2918074620 cites W2065148379 @default.
- W2918074620 cites W2067045743 @default.
- W2918074620 cites W2068200417 @default.
- W2918074620 cites W2068787629 @default.
- W2918074620 cites W2070937705 @default.
- W2918074620 cites W2071843907 @default.
- W2918074620 cites W2072718601 @default.
- W2918074620 cites W2073039264 @default.
- W2918074620 cites W2074061250 @default.
- W2918074620 cites W2075106941 @default.
- W2918074620 cites W2075401994 @default.
- W2918074620 cites W2076027168 @default.
- W2918074620 cites W2077032728 @default.
- W2918074620 cites W2079280846 @default.
- W2918074620 cites W2079504777 @default.
- W2918074620 cites W2079999509 @default.
- W2918074620 cites W2081861662 @default.
- W2918074620 cites W2083430591 @default.